Enlitic locks in $8M capital raise to propel AI healthcare expansion

Enlitic (ASX:ENL) has secured commitments for a capital raise of $8 million through the issuance of secured convertible notes to a group of sophisticated investors.

Approximately $2.6 million will be received immediately in the first tranche, with the remaining $5.4 million subject to shareholder approval.

The convertible notes, which mature on 30 September 2026, will be secured by a first-priority interest over all of Enlitic’s present and future tangible and intangible assets.

Holders may convert the notes into CHESS Depositary Interests in the company at an initial conversion price of $0.025 per note, with a post-maturity conversion price set at a 25% discount to the 10-day volume-weighted average price of CDIs.